A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever. 1977

R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick

Sera referred to the North Carolina Division of Health Services for rickettsial serology in 1974 were tested by complement fixation (CF), microimmunofluorescence (micro-IF), microagglutination (MA) and hemagglutination (HA) for antibodies against Rickettsia rickettsii. There was good agreement among micro-IF,MA and HA tests in detecting antibody responses to this agent, but the CF test was definitely less sensitive than the others, even in illnesses with classical clinical manifestations of Rocky Mountain spotted fever (RMSF). Some variables that seemed to influence the CF result were the slow rate of increase in antibody titers, timing of serum collection, early antibiotic treatment and possibly, the particular association of CF antibody response with the IgG immunoliobulin class. Greater use of these newer, but relatively untried, serodiagnostic procedures is recommended infuture studies of RMSF.

UI MeSH Term Description Entries
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012284 Rickettsia rickettsii A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.
D012373 Rocky Mountain Spotted Fever An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness. Sao Paulo Typhus,Typhus, Sao Paulo,Brazilian Spotted Fever,Rickettsia rickettsii Infection,Fever, Brazilian Spotted,Infection, Rickettsia rickettsii,Rickettsia rickettsii Infections,Spotted Fever, Brazilian
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
September 1976, JAMA,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
April 1979, Archives of internal medicine,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
April 1979, The New England journal of medicine,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
November 1980, Southern medical journal,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
August 2023, Journal of the Pediatric Infectious Diseases Society,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
August 1982, North Carolina medical journal,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
March 1949, Journal of the Medical Association of Georgia,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
January 1978, The New England journal of medicine,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
November 2007, The Lancet. Infectious diseases,
R N Philip, and E A Casper, and J N MacCormack, and D Sexton, and L A Thomas, and R L Anacker, and W Burgdorfer, and S Vick
September 1950, New York state journal of medicine,
Copied contents to your clipboard!